Over 169.5 million PCR tests have been conducted in the country so far.
coronavirus3 days ago
Kuwait's Ministry of Health has approved GSK and Vir Biotechnology's Sotrovimab as a treatment for coronavirus, state news KUNA reported on Wednesday.
Kuwait is the second country in the Middle East to approve the use of the antibody treatment for mild to moderate Covid-19 cases, after the UAE.
Kuwait also announced on Wednesday a $40 million donation to COVAX, the international program designed to help supply developing countries with vaccines against the disease, KUNA said.
Dr. Abdullah Al Badr, the assistant undersecretary for medicines and nutrition supervision, told Kuna the drug is used for such cases among adults and children aged 12 and above, Kuna reported.
He added that the medicine is also used for persons of 65 years of age and above, but not for hospitalised patients who need oxygen due to Covid-19 infection.
UAE approves new treatment for high-risk Covid patients
Clinical studies have shown that this medicine has lowered hospital admissions and deaths by 85 per cent. It prevents the virus from entering human cells.
(with inputs from Reuters)
Over 169.5 million PCR tests have been conducted in the country so far.
coronavirus3 days ago
Removes limitations on people attending weddings, funerals and places of worship
coronavirus3 days ago
Government authorises SKYCovione for two-dose regimen on people aged 18 or older
coronavirus3 days ago
Jab gets green light for those aged 18 years and above
coronavirus3 days ago
Total active cases stand at 17,422
coronavirus4 days ago
At-home health monitoring reduced to three days from seven
coronavirus4 days ago
The Gemcovac-19 shot has been tested on 4,000 people
coronavirus4 days ago
Online publishing, audiovisual platforms experienced growth due to reliance on digital content during pandemic
coronavirus5 days ago